Prediction of cognitive decline after stroke using proton magnetic resonance spectroscopy

Journal of the Neurological Sciences

Volumn 251, Issue 1-2, 2006, Pages 62-69

  Ross, Amy J ^a,b   Sachdev, Perminder S ^a   Wen, Wei ^a   Brodaty, Henry ^a   Joscelyne, Amy ^a   Lorentz, Lisa M ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Ageing; MRI; Proton magnetic resonance spectroscopy; Stroke; TIA; Vascular cognitive impairment

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; OCCIPITAL CORTEX; PARIETAL LOBE; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STROKE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASPARTIC ACID; BRAIN CHEMISTRY; CEREBROVASCULAR ACCIDENT; COGNITION DISORDERS; CREATINE; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROTONS; REFERENCE VALUES; TIME FACTORS;

EID: 33751227772     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.08.014     Document Type: Article

References (49)

1. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., MacMahon S., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Int Med 63 (2003) 1069-1075
2. Tham W., Auchus A.P., Thong M., Goh M.L., Chang H.M., Wong M.C., et al. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci 203-204 (2002) 49-52
3. Sachdev P.S., Brodaty H., Valenzuela M.J., Lorentz L.M., and Koschera A. Progression of cognitive impairment in stroke patients. Neurology 63 9 (2004) 1618-1623
4. Chodosh J., Reuben D.B., Albert M.S., and Seeman T.E. Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 50 6 (2002) 1051-1060
5. Tian J., Bucks R.S., Haworth J., and Wilcock G. Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry 74 4 (2002) 433-438
6. Waite L.M., Broe G.A., Grayson D.A., and Creasey H. Preclinical syndromes predict dementia: the Sydney older persons study. J Neurol Neurosurg Psychiatry 71 3 (2001) 296-302
7. Rusinek H., De Santi S., Frid D., Tsui W.H., Tarshish C.Y., Convit A., et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 229 3 (2003) 691-696
8. Mungas D., Reed B.R., Jagust W.J., DeCarli C., Mack W.J., Kramer J.H., et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 59 6 (2002) 867-873
9. Golomb J., Kluger A., de Leon M.J., Ferris S.H., Mittelman M., Cohen J., et al. Hippocampal formation size predicts declining memory performance in normal aging. Neurology 47 3 (1996) 810-813
10. Wolfson L., Wei X., Hall C.B., Panzer V., Wakefield D., Benson R.R., et al. Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility. J Neurol Sci 232 (2005) 23-27
11. Doraiswamy P.M., Charles H.C., and Krishnan K.R. Prediction of cognitive decline in early Alzheimer's disease. Lancet 352 9141 (1998) 1678
12. Garnett M.R., Blamire A.M., Corkill R.G., Cadoux-Hudson T.A., Rajagopalan B., and Styles P. Early proton magnetic resonance spectroscopy in normal-appearing brain correlates with outcome in patients following traumatic brain injury. Brain 123 Pt 10 (2000) 2046-2054
13. Fang H. Observations on aging characteristics of cerebral blood vessels, macroscopic and microscopic features. In: Terry R.D., and Gershon S. (Eds) (1976), Raven, New York 155-166
14. Gunning-Dixon F.M., and Raz N. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia 41 (2003) 1929-1941
15. Kovari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 35 2 (2004) 410-414
16. Filley C.M. The behavioral neurology of cerebral white matter. Neurology 50 (1998) 1535-1540
17. Wen W., Sachdev P.S., Chen X., and Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 29 4 (2006) 1031-1039
18. Almkvist O. Neuropsychological deficits in vascular dementia in relation to Alzheimer's disease: reviewing evidence for functional similarity or divergence. Dementia 5 (1994) 203-209
19. Parnetti L., Lowenthal D.T., Presciutti O., Pelliccioli G.P., Palumbo R., Gobbi G., et al. Senin U.1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 44 (1996) 133-138
20. Sachdev P.S., Brodaty H., Valenzuela M.J., Lorentz L., Looi J.C., Wen W., et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 62 6 (2004) 912-919
21. Goodglass H., and Kaplan E. The assessment of aphasia and related disorders (1983), Lea and Febiger, Philadelphia
22. Jorm A.F., and Jacomb P.A. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 19 4 (1989) 1015-1022
23. Wechsler D. Wechsler memory scale - revised (1987), The Psychological Corporation, New York
24. Wechsler D. Wechsler adult intelligence scale - revised (1981), The Psychological Corporation, New York
25. Mack W.J., Freed D.M., Williams B.W., and Henderson V.W. Boston naming test: shortened versions for use in Alzheimer's disease. J Gerontol 47 3 (1992) 154-158
26. Reitan R.M., and Wolfson D. The Halstead-Reitan neuropsychological test battery (1985), Neuropsychology Press, Tucson
27. Smith A. Symbol digit modalities test (1991), Western Psychological Services, Los Angeles
28. Kertesz Aed. Western aphasia battery (1983), The Psychological Corporation, San Antonia
29. Benton A.L., Hamsher Kd., Varney N.R., and Spreen O. Contributions to neuropsychological assessment (1983), Oxford University Press, New York
30. Strub R.I., and Black F.W. Mental status examination in neurology (1985), Davis, Philadelphia
31. Weigl E. On the psychology of so-called abstraction. J Norm Soc Psychol 36 (1941) 3-33
32. Benton A.L., and Hamsher Kd. Multilingual aphasia examination manual (1978), University of Iowa, Iowa City
33. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 9 (1989) 1159-1165
34. 1H-MRS measures in the healthy elderly. Brain Res Bull 66 1 (2005) 9-16
35. van den Boogaart A. MRUI MANUAL V. 96,3. A user's guide to the Magnetic Resonance User Interface Software Package (1997), Delft Technical University Press, Delft
36. Wen W., and Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage 22 1 (2004) 144-154
37. Watson C., Jack Jr. C.R., and Cendes F. Volumetric magnetic resonance imaging. Clinical applications and contributions to the understanding of temporal lobe epilepsy. Arch Neurol 54 12 (1997) 1521-1531
38. Terry R.D., DeTeresa R., and Hansen L.A. Neocortical cell counts in normal human adult aging. Ann Neurol 21 6 (1987) 530-539
39. Schaie K.W., Maitland S.B., Willis S.L., and Intrieri R.C. Longitudinal invariance of adult psychometric ability factor structures across 7 years. Psychol Aging 13 (1998) 8-20
40. Adalsteinsson E., Sullivan E.V., Kleinhans N., Spielman D.M., and Pfefferbaum A. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 355 9216 (2000) 1696-1697
41. Friedman S.D., Brooks W.M., Jung R.E., Hart B.L., and Yeo R.A. Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury. AJNR Am J Neuroradiol 19 10 (1998) 1879-1885
42. Suwanwelaa N., Phanuphak P., Phanthumchinda K., Suwanwela N.C., Tantivatana J., Ruxrungtham K., et al. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Res Imaging 18 7 (2000) 859-865
43. Valenzuela M.J., Sachdev P.S., Wen W., Shnier R., Brodaty H., and Gillies D. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes. Neuroimage 12 (2000) 747-756
44. Salat D.H., Kaye J.A., and Janowsky J.S. Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. Arch Neurol 56 (1999) 338-344
45. Tisserand D.J., van Boxtel M.P., Pruessner J.C., Hofman P., Evans A.C., and Jolles J. A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. Cereb Cortex 14 9 (2004) 966-973
46. Steingard R.J., Yurgelun-Todd D.A., Hennen J., Moore J.C., Moore C.M., Vakili K., et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry 48 11 (2000) 1053-1061
47. Kumar A., Thomas A., Lavretsky H., Yue K., Huda A., Curran J., et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 159 4 (2002) 630-636
48. 1H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases. Int J Geriatr Psychiatry 16 12 (2001) 1129-1135
49. Herminghaus S., Frolich L., Gorriz C., Pilatus U., Dierks T., Wittsack H.J., et al. Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopy. Psychiatry Res Neuroimaging 123 (2003) 183-190